MedTrace Logo

New IDEAS: Imaging Dementia-Evidence for Amyloid Scanning Study

NCT04426539 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6061

Last updated 2026-02-02

No results posted yet for this study

Summary

New IDEAS is an observational, open-label, longitudinal cohort study designed to address the requirements of the CED provisions of the NCD on beta-amyloid PET. Building on the initial Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) study, New IDEAS will evaluate the association between amyloid PET and patient-centered outcomes in an expanded and more ethnoracially and clinically diverse group of Medicare participants presenting with cognitive impairment.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Gil Rabinovici, MD · University of California, San Francisco

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-17
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04426539 on ClinicalTrials.gov